IHH Healthcare Berhad (KLSE:IHH)
Malaysia
· Delayed Price · Currency is MYR | Market Cap | 77.85B |
| Revenue (ttm) | 25.75B |
| Net Income (ttm) | 2.10B |
| Shares Out | 8.84B |
| EPS (ttm) | 0.24 |
| PE Ratio | 37.03 |
| Forward PE | 34.13 |
| Dividend | 0.11 (1.19%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 15,951,700 |
| Average Volume | 6,265,185 |
| Open | 8.77 |
| Previous Close | 8.77 |
| Day's Range | 8.73 - 8.89 |
| 52-Week Range | 6.42 - 10.48 |
| Beta | 0.17 |
| RSI | 49.31 |
| Earnings Date | May 26, 2026 |
About IHH Healthcare Berhad
IHH Healthcare Berhad, an investment holding company, offers healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Europe, and internationally. It provides primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services. The company also offers secondary care facilities, including medical emergencies and acute treatment, as well as specialist consultation, diagnostics, and lab services; tertiary care services comprising specialist consultative care, advanced treatm... [Read more]
Full Company ProfileFinancial Performance
In 2025, IHH Healthcare Berhad's revenue was 25.75 billion, an increase of 5.59% compared to the previous year's 24.38 billion. Earnings were 2.10 billion, a decrease of -20.93%.
Financial StatementsNews
Fortis Healthcare surges nearly 3% as IHH commits to raise stake to 50% from 31%
Shares of Fortis Healthcare jumped sharply today, rising 2.13% to ₹825.35 on the NSE after Malaysia’s IHH Healthcare publicly committed to increasing its shareholding in the Indian hospital chain to…
IHH Healthcare Bhd (XKLS:5225) Q4 2025 Earnings Call Highlights: Strong Financial Performance ...
IHH Healthcare Bhd (XKLS:5225) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic Growth Initiatives
Q4 2025 IHH Healthcare Bhd Earnings Call Transcript
Q4 2025 IHH Healthcare Bhd Earnings Call Transcript
IHH Healthcare Berhad Earnings Call Transcript: Q4 2025
Q4 2025 saw record revenue and EBITDA, with double-digit growth across key markets and strong margin performance. Malaysia and India led growth, while digital transformation and brownfield expansions drive future returns. Dividend payout increased, and outlook for 2026 remains positive.
Fortis Healthcare shares gain today after IHH Healthcare outlines India expansion plan
Friday, February 20: Shares of Fortis Healthcare Limited traded higher after its largest shareholder, IHH Healthcare Berhad, detailed plans to...
IHH Healthcare Berhad Earnings Call Transcript: Q3 2025
Q3 2025 saw double-digit constant currency growth in revenue and EBITDA, with strong performance across Malaysia, India, Turkey, and Europe, and stable margins despite FX and regulatory headwinds. Medical tourism and day care expansion drove growth, while CapEx guidance was revised lower to reflect strategic shifts.
IHH Healthcare Bhd (XKLS:5225) Q2 2025 Earnings Call Highlights: Resilient Growth Amid Challenges
IHH Healthcare Bhd (XKLS:5225) Q2 2025 Earnings Call Highlights: Resilient Growth Amid Challenges
Q2 2025 IHH Healthcare Bhd Earnings Call Transcript
Q2 2025 IHH Healthcare Bhd Earnings Call Transcript
IHH Healthcare Berhad Earnings Call Transcript: Q2 2025
Q2 2025 saw resilient financial results with 7% revenue and 2% EBITDA growth, and even stronger constant-currency gains, driven by increased admissions and a shift to daycare. Margins remained stable amid FX volatility and payer pressure, with robust segment performance and ongoing operational transformation.
IHH Healthcare Berhad Earnings Call Transcript: Q1 2025
Q1 2025 saw robust constant currency revenue and EBITDA growth, with resilience across geographies despite FX and payer headwinds. Malaysia, Turkey, India, and Hong Kong delivered strong operational results, while cost and digital initiatives support margin stability and future growth.
How the CEO of one Asia's largest healthcare providers is expanding despite soaring medical inflation
IHH Healthcare is one of Asia's largest healthcare providers, operating a network of hospitals, medical centers, clinics, and ambulatory centers across 10 markets.
IHH Healthcare Berhad Earnings Call Transcript: Q4 2024
Double-digit revenue and EBITDA growth in FY 2024, with strong performance across all markets and a higher dividend payout. Expansion and acquisitions drove capacity, while Malaysia faces medical inflation and payer pressure, mitigated by group diversification.
IHH Healthcare Bhd (XKLS:5225) Q3 2024 Earnings Call Highlights: Strong Revenue and EBITDA ...
IHH Healthcare Bhd (XKLS:5225) Q3 2024 Earnings Call Highlights: Strong Revenue and EBITDA Growth Amidst Margin Pressures
Q3 2024 IHH Healthcare Bhd Earnings Call Transcript
Q3 2024 IHH Healthcare Bhd Earnings Call Transcript
IHH Healthcare Berhad Earnings Call Transcript: Q3 2024
Q3 2024 saw robust revenue and EBITDA growth, driven by higher patient volumes and strategic acquisitions, notably Island Hospital. Margin pressures in Singapore and Malaysia are expected to be temporary, with strong cash flow and medical tourism supporting future expansion.
IHH Healthcare Berhad Transcript: M&A Announcement
The acquisition of Island Hospital for MYR 3.9 billion strengthens the northern cluster, enhances medical tourism leadership, and is expected to be EPS and ROE accretive by year two. Synergies of MYR 200 million are targeted over five years, with minimal CapEx needed for expansion.
Asian Buyout Firm Likely to Sell Malaysia Hospital to IHH Healthcare
Asian buyout firm Affinity Equity Partners is likely to sell its hospital in Malaysia to IHH Healthcare in a deal that could value the asset at over $900 million, people familiar with the process said...
Malaysian health care has 'several good things going for it': IHH Healthcare
Prem Kumar Nair, group CEO of IHH Healthcare, says the country has a good supply of trained manpower.
IHH Healthcare Bhd (XKLS:5225) Q2 2024 Earnings Call Transcript Highlights: Record Revenue and ...
IHH Healthcare Bhd (XKLS:5225) Q2 2024 Earnings Call Transcript Highlights: Record Revenue and Strong Growth Across Key Markets
IHH Healthcare Berhad Earnings Call Transcript: Q2 2024
Q2 2024 saw record revenue and double-digit growth in all key metrics, with strong performance across Malaysia, Singapore, Turkey/Europe, and India. Interim dividend was raised, and robust cash flow supports ongoing expansion, while medical tourism and specialty care remain growth drivers.